Venetoclax in Combination With Standard Induction and Consolidation Chemotherapy in Newly Diagnosed Young AML Patients
Clinical trial NCT06162325 · UNKNOWN
Trial details
- NCT number
- NCT06162325
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-01-21
- Primary completion
- 2024-12-31
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.